FGFR-IN-9 (Compound 19) is a potent, reversible and orally active FGFR inhibitor with an IC 50 of 17.1, 29.6, 30.7, 46.7 and 64.3 nM against FGFR4 WT , FGFR3, FGFR4 V550L , FGFR2 and FGFR1, respectively.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > FGFR
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。